In the following video, Motley Fool health-care analyst David Williamson discusses his take on the upcoming earnings report from St. Jude Medical (STJ), and what investors need to watch going forward.
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Foolish Preview: St. Jude Earnings
By Dave Williamson
–
Jan 22, 2013 at 8:07PM
NYSE: STJ
St. Jude Medical Inc.
After a difficult 2012, what will this quarter say about St. Jude in 2013?
David Williamson has no position in any stocks mentioned. The Motley Fool owns shares of St. Jude Medical. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned
St. Jude Medical Inc.
STJ
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles
Why St. Jude Medical, Inc. Acquired a Higher Price Today
How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock?
3 Charts Show Why Abiomed Could Get Bought
Why Abiomed Shares Jumped 13% in March
Why Abiomed, Inc. Shares Were Sent Soaring 137% in 2015
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.